Pathios

Developer of small molecule based therapeutics for the treatment of cancer

placeOxford, England, United Kingdom calendar_todayFounded 2017 groups9 employees language pathiostherapeutics.com

Registered entities

Social engagement

Social engagement: 3.7K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Brandon Capital.

Investor typeCountShare
Venture capital240%
Other / undisclosed360%

Recent activity

4 Jun 2026
Event
ASCO26 poster session
13 Nov 2025
Milestone
regulatory
Coming soon